Jubilant Pharmova share news, announcements and annual reports
NSE: JUBLPHARMABSE: 530019Pharmaceuticals & BiotechnologySmall Cap
Jubilant Pharmova Limited · Formerly Jubilant Life Sciences · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 1981 on BSE, Jun 2003 on NSE
Last close ₹946.00up ₹2.10 (0.22%)BSE ₹942.40
Share price at the NSE close on 29 Oct 2026. Previous close ₹943.90.
29 Oct: open ₹943.90, high ₹956.10, low ₹937.30
52-week range of traded prices to 29 Oct 2026
₹786.05Low, 9 Mar 2026₹1,183.00High, 4 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15,068 Cr422nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 42.79
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹59 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 36.64
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.12
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.53%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹59 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 6.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.45
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 45,19840.5% delivered
Jubilant Pharmova results
112 filed, newest first. Page 1 of 3.
Aug 2026
10 Aug · Results
May 2026
22 May · Results
Feb 2026
6 Feb · Results
Oct 2025
31 Oct · Results
Jul 2025
29 Jul · Results
May 2025
16 May · Results
Jan 2025
31 Jan · Results
Oct 2024
25 Oct · Results
Jul 2024
19 Jul · Results
May 2024
29 May · Results
Feb 2024
2 Feb · Results
Oct 2023
27 Oct · Results
Jul 2023
19 Jul · Results
May 2023
29 May · Results
Feb 2023
3 Feb · Results
Aug 2022
May 2022
27 May · Results
Feb 2022
4 Feb · Results
Oct 2021
22 Oct · Results
Jul 2021
23 Jul · Results
Jun 2021
4 Jun · Results
Feb 2021
5 Feb · Results
Nov 2020
4 Nov · Results
Sep 2020
4 Sep · Results
May 2020
29 May · Results
Jan 2020
31 Jan · Results
Oct 2019
25 Oct · Results
Jul 2019
26 Jul · Results
May 2019
17 May · Results
Feb 2019
1 Feb · Results
Oct 2018
22 Oct · Results
Jul 2018
27 Jul · Results
May 2018
9 May · Results
Jan 2018
17 Jan · Results
Oct 2017
28 Oct · Results
Jul 2017
18 Jul · Results
May 2017
23 May · Results
Feb 2017
7 Feb · Results
Oct 2016
27 Oct · Results
Aug 2016
May 2016
Feb 2016
Oct 2015
Aug 2015
May 2015
Feb 2015
Oct 2014
Aug 2014
May 2014